1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Emergence of new excipients for the pharmaceutical industry
4.1.2 Advances in nanotechnology imparting new functions to pharmaceutical excipients
4.1.3 Patent cliffs driving the growth of excipients in the generics market
4.1.4 Growth of the global pharmaceuticals market backed by functional excipients
4.2 Restraints
4.2.1 Risk of adverse reactions on the body
4.2.2 Declining R&D Investments
4.2.3 Increased regulatory requirements leading to shortage of FDA approved manufacturing sites
4.3 Opportunities
4.3.1 Shifting focus of pharmaceutical manufacturing to emerging countries
4.3.2 Multi-functionality excipients are proving to be emerging areas of new product developments
4.4 Challenges
4.4.1 Quality concerns
5. Asia-Pacific Pharmaceutical Excipients Market - By Process
5.1 Coatings & Films
5.2 Coloring agents
5.3 Flavoring agents
5.4 Lubricants
5.5 Glidants
5.6 Disintegrants
5.7 Binders
5.8 Diluents
6. Asia-Pacific Pharmaceutical Excipients Market - By Type of Product
6.1 Organic Chemicals
6.2 Inorganic Chemicals
7. Asia-Pacific Pharmaceutical Excipients Market - By Country
7.1. Introduction
7.2. India
7.3. China
7.4. Japan
7.5 Rest of Asia-Pacific
8. Company Profiles
8.1 The Lubrizol Corporation
8.2 The Dow Chemical Company
8.3 J.M. Huber Corporation
8.4 Innophos Holdings Inc.,
8.5 Croda International PLC
8.6 Colorcon, Inc.
8.7 Archer Daniels Midland Company
8.8 AkzoNobel
8.9 Ashland Inc.
8.10 Associated British Foods PLC
8.11 BASF SE,
8.12 Evonik Industries AG
8.13 FMC Corporation
8.14 Merck Millipore
8.15 Roquette Group
9. Asia-Pacific Pharmaceutical Excipients Market - Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
